ããŒã«ãã«ã°ãŠã€ã«ã¹ã¯ã1967幎ã«åããŠå ±åãããæ¯èŒççããåºè¡ç±ã§ãããé¢é£ããæ»äº¡è
æ°ã¯åèš376人ã§ã2005幎以éã®æ»äº¡è
æ°ã¯16人ã«ãšã©ãŸã£ãŠããŸãã
ãã©ã€ããŒãã¶ã€ã³ç€Ÿã¯ã2018幎ã«ããŒã«ãã«ã°åºè¡ç±ã®ã¯ã³ã¹ãããã»ãªã¢ã«ã¿ã€ã PCRæ€æ»ãgenesig®ããéçºããŸããã
ãªãã2005幎以éã倧ããªæµè¡ããªãç æ°ã®ããã«ã2018幎ã«ãã¹ããéçºããã®ã§ããããïŒãœãªãžã§ããã¯ã¹ç€Ÿã¯çŸåšãããŒã«ãã«ã°åºè¡ç±çšã®ãªã·ã³ãªããã¯ã¯ãã³ãRiVax®ãã®æ²»éšãæ¥ãã§ããŸããRiVaxã¯ç±³åœFDAã«ãããªã·ã³äžæ¯äºé²ã®ãã¡ã¹ããã©ãã¯æå®ãåããŠãã....
COVID-19ãã³ãããã¯ã®æé ãšãã®æãããªå€±æãããç§ã¯åœæ°ãæ²¹æããŠããéã«ç¬¬2段éãŸãã¯æçµçãªè§£æ±ºçãçšæãããŠããã®ã§ã¯ãªãããšèããŠããã
åºè¡ç±ã®çç¶ã¯ãç é¢ãè人ããŒã ã®å人ãšãªã£ãŠããCOVID泚å°ã§å·ã€ããè匱ãªæ£è ã«COVIDããŒã¹ã¿ãŒæ³šå°ã匷èŠããããã«åäŸãã¡ã«ã泚å°ããããšã§ãç°¡åã«å¢å ãããç®ç«ãããããšãã§ããã
åºè¡ç±ã®çç¶ã¯ã巚倧ãªããŒã«ãã«ã°ã»ãã³ãããã¯ãšããŠçŸããæ°ããããŒã«ãã«ã°PCRæ€æ»ã§ç¢ºèªããããšãã§ããäžçãçµéšããããšã®ãªããããªéå£ãã¹ããªãŒãåŒãèµ·ããã ããã
ãã©ã€ããŒãã¶ã€ã³ç€Ÿã¯ã2018幎ã«ããŒã«ãã«ã°åºè¡ç±ã®ã¯ã³ã¹ãããã»ãªã¢ã«ã¿ã€ã PCRæ€æ»ãgenesig®ããéçºããŸããã
ãªãã2005幎以éã倧ããªæµè¡ããªãç æ°ã®ããã«ã2018幎ã«ãã¹ããéçºããã®ã§ããããïŒãœãªãžã§ããã¯ã¹ç€Ÿã¯çŸåšãããŒã«ãã«ã°åºè¡ç±çšã®ãªã·ã³ãªããã¯ã¯ãã³ãRiVax®ãã®æ²»éšãæ¥ãã§ããŸããRiVaxã¯ç±³åœFDAã«ãããªã·ã³äžæ¯äºé²ã®ãã¡ã¹ããã©ãã¯æå®ãåããŠãã....
COVID-19ãã³ãããã¯ã®æé ãšãã®æãããªå€±æãããç§ã¯åœæ°ãæ²¹æããŠããéã«ç¬¬2段éãŸãã¯æçµçãªè§£æ±ºçãçšæãããŠããã®ã§ã¯ãªãããšèããŠããã
åºè¡ç±ã®çç¶ã¯ãç é¢ãè人ããŒã ã®å人ãšãªã£ãŠããCOVID泚å°ã§å·ã€ããè匱ãªæ£è ã«COVIDããŒã¹ã¿ãŒæ³šå°ã匷èŠããããã«åäŸãã¡ã«ã泚å°ããããšã§ãç°¡åã«å¢å ãããç®ç«ãããããšãã§ããã
åºè¡ç±ã®çç¶ã¯ã巚倧ãªããŒã«ãã«ã°ã»ãã³ãããã¯ãšããŠçŸããæ°ããããŒã«ãã«ã°PCRæ€æ»ã§ç¢ºèªããããšãã§ããäžçãçµéšããããšã®ãªããããªéå£ãã¹ããªãŒãåŒãèµ·ããã ããã